TCG Crossover Management, LLC
54 holdingsFiling period: 2026-06-30Current AUM: $3.75Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ABVX | Abivax SA American Depositary Shares | 6.01M | $800.6M | $539.7M | 14.41% | -473,251 | 2026-06-30 |
| 2 | TNGX | Tango Therapeutics Inc | 9.08M | $283.9M | $201.9M | 5.39% | -1,449,870 | 2026-06-30 |
| 3 | CGON | CG Oncology Inc | 3.67M | $260.8M | $234.7M | 6.27% | -- | 2026-06-30 |
| 4 | COGT | Cogent Biosciences Inc | 4.85M | $187.9M | $156.5M | 4.18% | -92,458 | 2026-06-30 |
| 5 | IMVT | Immunovant Inc | 4.46M | $171.8M | $131.2M | 3.50% | -- | 2026-06-30 |
| 6 | SYRE | Spyre Therapeutics Inc | 1.90M | $168.7M | $189.6M | 5.06% | -- | 2026-06-30 |
| 7 | DNTH | Dianthus Therapeutics Inc | 1.68M | $163.4M | $138.0M | 3.68% | -- | 2026-06-30 |
| 8 | MIRM | Mirum Pharmaceuticals Inc | 1.06M | $124.3M | $91.1M | 2.43% | -- | 2026-06-30 |
| 9 | ZLAB | Zai Lab Ltd-ADR | 6.14M | $116.6M | $141.4M | 3.77% | -- | 2026-06-30 |
| 10 | AMLX | Amylyx Pharmaceuticals Inc | 6.24M | $112.1M | $175.3M | 4.68% | -- | 2026-06-30 |
| 11 | GLUE | Monte Rosa Therapeutics Inc | 4.62M | $111.9M | $50.2M | 1.34% | -- | 2026-06-30 |
| 12 | BCRX | Biocryst Pharmaceuticals Inc | 11.02M | $110.2M | $92.2M | 2.46% | -- | 2026-06-30 |
| 13 | VOR | Vor Biopharma Inc | 5.67M | $104.4M | $117.1M | 3.13% | -- | 2026-06-30 |
| 14 | TYRA | Tyra Biosciences Inc | 3.25M | $103.8M | $70.7M | 1.89% | -- | 2026-06-30 |
| 15 | DYN | Dyne Therapeutics Inc | 4.62M | $102.5M | $78.4M | 2.09% | -- | 2026-06-30 |
| 16 | IRON | Disc Medicine Inc | 1.34M | $98.1M | $111.6M | 2.98% | -- | 2026-06-30 |
| 17 | RLAY | Relay Therapeutics Inc | 4.27M | $80.0M | $84.1M | 2.25% | -- | 2026-06-30 |
| 18 | SVRA | Savara Inc | 12.36M | $76.2M | $62.1M | 1.66% | -- | 2026-06-30 |
| 19 | AURA | Aura Biosciences Inc | 9.53M | $67.7M | $61.0M | 1.63% | -- | 2026-06-30 |
| 20 | RVMD | Revolution Medicines Inc | 340.9K | $63.8M | $64.3M | 1.72% | -235,574 | 2026-06-30 |
| 21 | TRAX | First Tracks Biotherapeutics | 2.90M | $58.3M | $132.4M | 3.53% | -- | 2026-06-30 |
| 22 | KOD | Kodiak Sciences Inc | 1.45M | $56.3M | $140.3M | 3.74% | -- | 2026-06-30 |
| 23 | AVTX | Avalo Therapeutics Inc | 3.02M | $55.8M | $21.5M | 0.57% | +2.28M | 2026-06-30 |
| 24 | LBRX | LB Pharmaceuticals Inc | 1.45M | $47.0M | $57.6M | 1.54% | -392,179 | 2026-06-30 |
| 25 | IPSC | Century Therapeutics Inc | 17.75M | $43.4M | $26.6M | 0.71% | -- | 2026-06-30 |
← Scroll →
Page 1 of 3